Advertisement
UK markets closed

  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     

  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     

  • AIM

    755.28
    +2.16 (+0.29%)
     

  • GBP/EUR

    1.1675
    +0.0019 (+0.16%)
     

  • GBP/USD

    1.2490
    -0.0021 (-0.17%)
     

  • Bitcoin GBP

    50,980.30
    -534.56 (-1.04%)
     

  • CMC Crypto 200

    1,383.71
    -12.82 (-0.96%)
     

  • S&P 500

    5,110.17
    +61.75 (+1.22%)
     

  • DOW

    38,301.39
    +215.59 (+0.57%)
     

  • CRUDE OIL

    83.91
    +0.34 (+0.41%)
     

  • GOLD FUTURES

    2,346.10
    +3.60 (+0.15%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     

  • DAX

    18,161.01
    +243.73 (+1.36%)
     

  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     
PROPERTY:

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

Why Moderna Stock Dropped Today

Joe Tenebruso, The Motley Fool
·3-min read
Why Moderna Stock Dropped Today

Shares of Moderna (NASDAQ: MRNA) plunged on Wednesday, following reports that several of the participants in its novel coronavirus vaccine trial suffered an adverse reaction to its experimental drug mRNA-1273. Moderna's stock surged 20% on May 18 after it shared positive results from its phase 1 study for its COVID-19 vaccine candidate mRNA-1273. Since that day, Moderna's stock has shed more than a third of its value, as analysts questioned both the timing of the stock sale and whether the preliminary data justified the price at which shares were sold.

Continue reading